Logo

Toshiba Licenses DNA Chip Patents to Antara, Says Move is Major Step in Its IVD Plans

Mar 10, 2006

NEW YORK , March 10 (GenomeWeb News) - Antara Biosciences has licensed from Toshiba patents to its DNA chips and electrochemical DNA analysis system for in vitro diagnosis, Toshiba said today.

 

Under the agreement, Antara, a California-based company started by the Tokyo-based Eurus Genomics, will develop the products for US Food and Drug Administration approval.

 

Toshiba said the deal "is a major step ... toward establishing the methadology as a core methodology for DNA-based diagnostics."

 

Financial details were not released.

Breaking News
The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.